BOSTON, Jan. 15, 2025 (GLOBE NEWSWIRE) — Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”) and Bispecific ADCs (“BsADCs), announced that it has been selected to participate in Seed Showcase, part of Biotech Showcase™ 2025.
Radiance will also be available virtually through the RESI JPM 2025 and Bio Partnering @JPM Week portals.
“We are delighted to announce that Radiance Biopharma was chosen to present at Biotech Showcase 2025 in San Francisco,” said Robert Brooks, JD, Chief Executive Officer, of Radiance. “We are eager to meet potential investors at the Biotech Showcase in person, and virtually through the RESI JPM 2025, and BIO Partnering @JPM portals.
Presentation Details:
Date: Wednesday, January 15, 2025 Time: 2:10 PM PT
Track: Franciscan B (Ballroom Level)
Biotech Showcase – Seed Showcase 2024 Hilton San Francisco – Union Square
333 O’Farrell Street, Ballroom Level San Francisco, CA 94102
About Biotech Showcase & Seed Showcase™
Now in its 17th year, Biotech Showcase™ is a well-established, highly respected conference featuring multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.
About Radiance Biopharma
Radiance is focused on developing a pipeline of antibody-based cancer therapeutics including mono and bispecific Antibody Drug Conjugates (ADCs) for the treatment of cancer.
Contacts
For more information, please visit www.radiancebiopharma.com.
Contact us at Info@radiancebiopharma.com
Office Tel. 617.621.7143


Đề xuất
PHONO Marks 20th Anniversary and Secures New Orders at RE+ 2026
A Seattle Startup Brings Your Pet to Life on Your Phone and Laptop With the Avatar Mirroring Their Every Move in Real Time
HEARTBOT AI Wins Chunghwa Telecom Special Award at Meet Neo Star 2026
Allooloo Tops 100M Capital Markets AI Agent Traffic a Month
KONST Showcases “24/7 GPUs Delivered in Asia” at SC26, Offering AI Compute Services from Validation and Delivery to Round-the-Clock Operations
APEC CEO Summit 2026 Concludes Successfully in Shenzhen